Trials / Completed
CompletedNCT00145002
A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)
Phase III Study of VCAP-AMP-VECP vs. Biweekly CHOP in Aggressive Adult T-cell Leukemia-lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 130 (planned)
- Sponsor
- Japan Clinical Oncology Group · Academic / Other
- Sex
- All
- Age
- 15 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To test the superiority of VCAP-AMP-VECP regimen over biweekly-CHOP in aggressive ATLL in terms of survival benefit.
Detailed description
Nothing to describe.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VCAP-AMP-VECP with G-CSF and intrathecal prophylaxis | |
| DRUG | biweekly-CHOP with G-CSF and intrathecal prophylaxis |
Timeline
- Start date
- 1998-08-01
- Completion
- 2004-12-01
- First posted
- 2005-09-05
- Last updated
- 2016-09-22
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00145002. Inclusion in this directory is not an endorsement.